Analysis of the United States Glaucoma Pharmaceuticals Market

Significant Opportunity Available to Address Unmet Needs


This research service covers the United States glaucoma pharmaceuticals market from 2008 to 2016, with 2010 as the base year. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: prostaglandins, beta-blockers, alpha-adrenerigic agonists, carbonic anhydrase inhibitors, and fixed-dose combinations.

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

Table of Contents

Analysis of the United States Glaucoma Pharmaceuticals Market, United States Glaucoma Pharmaceuticals MarketAnalysis of the United States Glaucoma Pharmaceuticals MarketResearch Service




Related Research

Release Date : 18-Aug-17

Region : North America

Release Date : 17-Aug-17

Region : North America

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.